Citation: | ZHU Ling, QIN Chao, WU Jinlian, CHEN Yuhong, YIN Lifang. Preparation and in vitro evaluation of pregabalin controlled porosity osmotic pump tablets[J]. Journal of China Pharmaceutical University, 2019, 50(1): 53-58. DOI: 10.11665/j.issn.1000-5048.20190107 |
[1] |
Li Z,Taylor CP,Weber M,et al.Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits.[J].Eur J Pharmacol,2011,667(1/2/3):80-90.
|
[2] |
Stahl SM, Porreca F, Taylor CP, et al. The diverse therapeutic actions of pregabalin:is a single mechanism responsible for several pharmacological activities[J]?Trends Pharmacol Sci,2013,34(6):332-339.
|
[3] |
Tassone DM,Boyce E,Guyer J,et al.Pregabalin:a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain,partial-onset seizures,and anxiety disorders[J].Clin Ther,2007,29(1):26-48.
|
[4] |
Bockbrader HN,Radulovic LL,Posvar EL,et al.Clinical pharmacokinetics of pregabalin in healthy volunteers[J].J Clin Pharmacol,2010,50(8):941-950.
|
[5] |
Shokri J,Ahmadi P,Rashidi P,et al.Swellable elementary osmotic pump(SEOP):an effective device for delivery of poorly water-soluble drugs[J].Eur J Pharm Biopharm,2008,68(2):289-297.
|
[6] |
Chen FW,Guo Z,Li HY,et al.Correlation of Fuzilizhong chemome release from osmotic pump tablets and intrinsic dissolution characteristics from powders[J].J China Pharm Univ(中国药科大学学报),2012,43(4):329-333.
|
[7] |
Li XD,Pan WS,Nie SF,et al.Studies on controlled release effervescent osmotic pump tablets from traditional chinese medicine compound recipe[J].J Control Release,2004,96(3):359-367.
|
[8] |
Adibkia K,Hanaee J,Ghanbarzadeh S,et al.Micro-suspension coating method:a new approach in formulation and development of controlled porosity osmotic pump systems[J].Drug Res,2013,64(4):203-207.
|
[9] |
Kanagale P,Lohray BB,Misra A,et al.Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.[J].AAPS Pharmscitech,2007,8(3):E13-E19.
|
[10] |
Li GJ,Wang YJ,Chen HM,et al.Can semipermeable membranes coating materials influence in-vivo performance for paliperidone tri-layer ascending release osmotic pump tablet: in vitro evaluation and in vivo pharmacokinetics study[J].Asian J Pharm Sci,2015,10(2):128-137.
|
[11] |
He W,Xue WD,Tang B.Optimization Test Design Method and Data Analysis[M]. Chemical Industry Press(化学工业出版社),2012.
|
[12] |
Mohanty S,Sahu M,Sirisha A.Osmotic pump a novel approach to control drug delivery[J].Indo Am J Pharm Res,2014,4(5):2367-2373.
|
[13] |
Xu XH,Liao LY,Jiang T. Release mechanism of PNS microporous membrane osmotic pump tablets[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2012,18(8):12-14.
|
[1] | YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202 |
[2] | LUO Xuelian, WU Chengsheng, ZHA Cheng, LIU Sheng. Research progress and prospects of implantable drug delivery systems for postoperative tumor therapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 538-547. DOI: 10.11665/j.issn.1000-5048.2024040901 |
[3] | WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902 |
[4] | YU Jiayu, LIN Zezhi, CAO Wei, ZHANG Jianjun, WEI Yuanfeng, GAO Yuan, QIAN Shuai. Research progress of bio-metal organic frameworks in drug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 23-33. DOI: 10.11665/j.issn.1000-5048.20221111003 |
[5] | ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403 |
[6] | LI Haoxian, LIN Huaqing, CHEN Jingwen, WANG Liyuan. Research progress of carbon nanomaterials in cancer drug delivery[J]. Journal of China Pharmaceutical University, 2019, 50(1): 100-106. DOI: 10.11665/j.issn.1000-5048.20190114 |
[7] | FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302 |
[8] | CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203 |
[9] | WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303 |
[10] | TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572. |